Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

MGF Igf-1-ec

IGF-1Ec, IGF-1Eb, Mechano-Growth Factor

Quick Stats
Studies 62
Trials 100
Completed NA INTERVENTIONAL NCT01561131

The Effect of Protein and Calcium on Weight Change and Blood Lipid Profile

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The primary aim is to examine the effect of a high protein intake (from soy or whey protein) on weightmaintenance after weight loss in a group of predisposed (severe) obese persons. Furthermore, to examine short-term and long-term effect of a high protein intake on appetite regulation and diet induced thermogenese (DIT). Finally to examine the effect of calcium on weightmaintence, bloodlipid profilen, appetite regulation and DIT. The study is a parallel RCT with a weight loss (WL) period (8 weeks on very low calorie diet) and a weightmaintence (WM) period (24 weeks daily intake of supplement). 200 overweight/obese subjects will be enrolled into the study and randomized to placebo (maltodextrin), soy protein, whey protein or calcium enriched whey protein supplement. At baseline (week 0), after the WL period (week 8) and after WM period (week 24) body weight and composition will be measured and blood samples will be collected. Meal test will be performed at week 0 and 24 (examining both appetite regulation and DIT). Urine and feces will be collected three times during the study. Subjects will receive dietary counseling (in groups) regularly during the study and body weight will be measured at each visit.

Interventions

Name: Whey protein
Type: DIETARY_SUPPLEMENT
Description: 45g protein/d; Dosage 3x15g protein daily
Name: Whey protein enriched with calcium
Type: DIETARY_SUPPLEMENT
Description: 45g protein/d + 1000mg calcium/d; dosage: 15g protein + 333mg calcium x 3 daily
Name: Soy protein
Type: DIETARY_SUPPLEMENT
Description: 45g soy protein/d; dosage 15g soy protein x 3 daily
Name: Maltodextrin
Type: DIETARY_SUPPLEMENT
Description: 48g carbohydrate/d; dosage: 16g carbohydrate x 3 daily

Primary Outcomes

Measure: Difference in body weight and composition during the weight maintenance period
TimeFrame: 24 weeks
Description:

Trial Information

NCT ID

NCT01561131

Status

Completed

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

University of Copenhagen

Last Updated

December 15, 2025